Navigation Links
QB3 signs agreement to accelerate innovation
Date:10/26/2011

The California Institute for Quantitative Biosciences (QB3) has signed an agreement with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) to fund University of California proof-of-concept research that brings innovative science to market.

This agreement, along with the Rogers Family Foundation of Oakland, helps fund QB3's "Bridging-the-Gap" program, initiated in 2008 to support scientific projects that have high commercial potential led by faculty at UCSF, UC Berkeley and UC Santa Cruz. These awards are intended to address the critical gap between federal funding for basic research and investments in product development. Each award typically provides $250,000 over two years for research.

Former award-winning projects include a prototype of an artificial kidney developed by Shuvo Roy, UCSF professor of bioengineering and therapeutic sciences, and an automated technique to improve prostate cancer screening, invented by Amy Herr, UC Berkeley associate professor of bioengineering.

The agreement establishes the JJSI-QB3 Awards as a component of the "Bridging-the-Gap" program and calls for annual awards over the next three years. QB3 will provide the awarded projects with services from the QB3 Startup-In-A-Box program, and potentially find space in the QB3 incubator.

"This agreement is an innovative academic-industry partnership model specifically focused on startup formation," said Neena Kadaba, QB3's director of industry alliances. "These awards are designed to provide a crucial amount of pre-commercial support to help would-be entrepreneurs address potential scientific risks in their technology before launching a company."

The nine projects funded by QB3's "Bridging-the-Gap" program to date already have resulted in five new companies and three licenses to existing firms. The five companies formed in the past two years have raised over $9 million in private and public commercial funding.

"This agreement represents an important initiative for QB3 by providing additional opportunities for innovative researchers at our universities to create companies of value," said Regis Kelly, director of QB3.


'/>"/>

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

Related biology news :

1. Hold the phone for vital signs
2. Wiley-Blackwell signs three new international open access agreements
3. Wireless network in hospital monitors vital signs
4. Reclamation signs research agreement to improve quagga and zebra mussel larvae detection
5. MU signs $5 million agreement with Coulter Translational Research Partnership Program
6. Epitomics Signs Agreement With Bayer for Antibody Technology
7. Young graphite in old rocks challenges the earliest signs of life
8. 5-minute screen identifies subtle signs of autism in 1-year olds
9. New test shows promise for detecting warning signs of joint replacement failure
10. Study provides new tool to monitor coral reef vital signs
11. Eurofins MWG Operon signs contract to supply DNA sequencing services to Research Councils
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global ... reach $11.4 billion by 2021, growing at a compound annual ... - An overview of the global markets for synthetic biology. ... estimates for 2016, and projections of compound annual growth rates ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... ... February 28, 2017 , ... ... of antibody therapeutics from millions-diverse immune repertoires, today announced a strategic partnership with ... strains genetically engineered to express human antibodies. The partnership will use GigaGen technology ...
(Date:2/28/2017)... , Feb. 28, 2017  ITL Limited ... company, supplier and strategic partner that provides innovative ... individual health management, formally announces its rebrand to ... name change is part of the Company,s unified ... launch of an integrated corporate website, ITLHealthGroup.com ...
(Date:2/28/2017)... and NEW YORK , February ... License Application accepted by the FDA for avelumab  ... disease has metastasized   ... Germany , in the US and ... US Food and Drug Administration (FDA) has accepted for Priority ...
(Date:2/27/2017)... -- A Europe-wide survey of institutes conducted by the ... their research treat them with due care. The survey polled a ... the results indicates that there is a strong commitment among animal ... the principles of the 3Rs (Refine, Reduce, Replace)  ... What are the 3Rs? ...
Breaking Biology Technology: